Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

NCT04367350 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04367350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04367350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Unknown status
Start date
March 20, 2020
Completion date
March 31, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, myocarditis, myositis, sars-cov2